We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 ...

The new insights on osteosarcome could, with time, lead to better treatment options and outcomes for patients through more ...

引言近年来，基因组学领域取得了飞速发展，尤其是全基因组测序（Whole Genome Sequencing, WGS）的普及，使得研究人员能够全面分析人类及其他物种的基因组数据。然而，人类基因组中约98%的区域为非编码区（Noncoding ...

Study identifies a novel mechanism driving osteosarcoma and provides insights to help predict patient outcomes ...

We recently compiled a list of the 10 Firms Drop on Bearish Statements, Disappointing Earnings. In this article, we are going ...

New genetic research on the Alaska red king crab reveals previously undiscovered diversity among different regions, ...

The newly unveiled database showcases the genome sequences of healthy individuals from 99 ethnic populations of the country, ...

Whole-genome sequencing of endangered cockatoo species brings new insights into their genetics, potentially offering fresh ...

In a report released today, Ryan MacDonald from Needham reiterated a Buy rating on Tempus AI, Inc. Class A (TEM – Research Report), with a ...